Screening of metabolic syndrome in children and adolescents

Authors

DOI:

https://doi.org/10.22141/2224-0721.18.2.2022.1153

Keywords:

metabolic syndrome, screening, additional markers, children, adolescents

Abstract

Background. Metabolic syndrome (MS) is perceived as a cluster of risk factors for cardiovascular disease and type 2 diabetes. The prevalence of MS in children and adolescents rea­ches 6–39 % depending on the identification criteria. Despite the considerable attention paid to MS in children and adolescents, there is no unified agreed consensus on its early scree­ning. Consequently, the purpose of the study was along with the gene­rally accepted criteria evaluate additional markers for MS early screening in children and adolescents. Materials and methods. A cross sectional study was conducted with 155 children aged 9–18 years, which formed 2 groups: a group of children with MS — 90 children with MS on the background of abdominal obesity and a group of children without MS — 65 children with normal body weight. Clinical (antrometric data, blood pressure) and laboratory (fasting glucose, fasting insulin, lipids) parameters were assessed. MS verification was performed according to the recommendations of the IDF Сonsensus (2007). Results. For MS screening in addition to the generally accepted criteria accor­ding to IDF Consensus (2007): abdominal obesity (waist circumference > 90th percentile according to age and gender), fasting glucose > 5.6 mmol/l, triglycerides > 1.7 mmol/l, blood pressure > 130/85 mm Hg, the most probable additional markers were established: neck and hip circumference, waist/hip ratio, body surface area > 90th percentile of distribution according to age and sex, fasting insulin > 15.0 mU/l, homeostasis model assessment for insulin ratio (HOMA-IR) > 2.8, total cholesterol > 5.2 mmol/l, LDL-C > 3.25 mmol/l, VLDL-C > 0.78 mmol/l, blood pressure in terms of distribution > 95th percentile, which contributes to its early detection and correction. Conclusions. Expanding the list of MS additional markers for its early screening in the pediatric and adolescent population is relevant and provides a basis for its timely correction and prevention.

Downloads

Download data is not yet available.

References

Grootendorst DC, Jager KJ, Zoccali C, Dekker FW. Screening: why, when, and how. Kidney Int. 2009 Oct;76(7):694-9. doi: 10.1038/ki.2009.232.

Smith RA. Can we improve on Wilson and Jungner's principles of screening for disease? CMAJ. 2018 Apr 9;190(14):E414-E415. doi: 10.1503/cmaj.180330.

Costa RF, Santos NS, Goldraich NP, Barski TF, Andrade KS, Kruel LF. Metabolic syndrome in obese adolescents: a comparison of three different diagnostic criteria. J Pediatr (Rio J). 2012 Jul;88(4):303-9. doi: 10.2223/JPED.2200.

Silveira LS, Buonani C, Monteiro PA, Antunes BMM, Freitas Júnior IF. Metabolic syndrome: criteria for diagnosing in children and adolescents. Endocrinol Metab Synd. 2013;2(3):118 doi. 10.4172/2161-1017.1000118.

Thomas NE, Rowe DA, Murtagh EM, Stephens JW, Williams R. Associations between metabolic syndrome components and markers of inflammation in Welsh school children. Eur J Pediatr. 2018 Mar;177(3):409-417. doi: 10.1007/s00431-017-3065-y.

Bussler S, Penke M, Flemming G, et al. Novel Insights in the Metabolic Syndrome in Childhood and Adolescence. Horm Res Paediatr. 2017;88(3-4):181-193. doi: 10.1159/000479510.

Peña-Espinoza BI, Granados-Silvestre MLÁ, Sánchez-Pozos K, Ortiz-López MG, Menjivar M. Metabolic syndrome in Mexican children: Low effectiveness of diagnostic definitions. Endocrinol Diabetes Nutr. 2017;64(7):369-376. (in English, Spanish). doi: 10.1016/j.endinu.2017.04.004.

Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103(6 Pt 1):1175-82. doi: 10.1542/peds.103.6.1175.

Andrabi SM, Bhat MH, Andrabi SR, et al. Prevalence of metabolic syndrome in 8-18-year-old school-going children of Srinagar city of Kashmir India. Indian J Endocrinol Metab. 2013;17(1):95-100. doi: 10.4103/2230-8210.107812.

Dutka R, Chmyr H, Svitlyk H, Leontieva Z. Prolactin, cortisol, free thyroxine and thyroid-stimulating hormone-markers of staging of metabolic syndrome as a risk factor for coronary artery disease and type 2 diabetes mellitus. Georgian Med News. 2019 Dec;(297):80-83.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.

Handelsman Y, Mechanick JI, Blonde L,; AACE Task Force for Developing Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011 Mar-Apr;17 Suppl 2:1-53. doi: 10.4158/ep.17.s2.1.

Zimmet P, Alberti KG, Kaufman F, et al. IDF Consensus Group. The metabolic syndrome in children and adolescents – an IDF Consensus report. Pediatr Diabetes. 2007;8(5):299-306. doi: 10.1111/j.1399-5448.2007.00271.x.

Dündar İ, Akıncı A. Prevalence of type 2 diabetes mellitus, metabolic syndrome, and related morbidities in overweight and obese children. J Pediatr Endocrinol Metab. 2022 Jan 17;35(4):435-441. doi: 10.1515/jpem-2021-0271.

De Lorenzo A, Gratteri S, Gualtieri P, Cammarano A, Bertucci P, Di Renzo L. Why primary obesity is a disease? J Transl Med. 2019;17(1):169. doi: 10.1186/s12967-019-1919-y.

Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a Disease: The Obesity Society 2018 Position Statement. Obesity (Silver Spring). 2019;27(1):7-9. doi: 10.1002/oby.22378.

Christian AH, Mochari H, Mosca LJ. Waist circumference, body mass index, and their association with cardiometabolic and global risk. J Cardiometab Syndr. 2009;4(1):12-9. doi: 10.1111/j.1559-4572.2008.00029.x.

Falalyeyeva T, Mamula Y, Scarpellini E, et al. Probiotics and obesity associated disease: an extended view beyond traditional strains. Minerva Gastroenterol (Torino). 2021;67(4):348-356. doi: 10.23736/S2724-5985.21.02909-0.

Magalhães EIS, Sant'Ana LFR, Priore SE, Franceschini SCC. Waist circumference, waist/height ratio, and neck circumference as parameters of central obesity assessment in children. Rev Paul Pediatr. 2014;32(3):273-81. doi: 10.1590/0103-0582201432320.

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998 Jul;15(7):539-53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.

Bochar OM, Sklyarova HY, Abrahamovych KY, Hromnats'ka NM, Bochar VT, Sklyarov EY. Metabolic syndrome, overweight, hyperleptinemia in children and adults. Wiadomosci Lekarskie. 2021;74 (2): 313-6.

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555-76.

Botsiurko V, Didushko O, Kostitska I. Do we need a diagnosis of metabolic syndrome? International Journal of Endocrinology (Ukraine). 2018;14(6):590-592. doi: 10.22141/2224-0721.14.6.2018.146070.(in Ukrainian).

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80. doi: 10.1111/j.1464-5491.2006.01858.x.

Christian Flemming GM, Bussler S, Körner A, Kiess W. Definition and early diagnosis of metabolic syndrome in children. J Pediatr Endocrinol Metab. 2020 Jul 28;33(7):821-833. doi: 10.1515/jpem-2019-0552.

Zhao Y, Yingjie YuY, Hong Li, Li M, et al. The association between metabolic syndrome and biochemical markers in Beijing adolescents. Int J Environ Res Public Health. 2019;16(22):4557. doi: 10.3390/ijerph16224557.

Published

2022-04-22

How to Cite

Gromnatska, N., Lemishko, B., Kulya, O., Pasichna, I., & Beliusova, V. (2022). Screening of metabolic syndrome in children and adolescents. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 18(2), 94–99. https://doi.org/10.22141/2224-0721.18.2.2022.1153

Issue

Section

Original Researches